tiprankstipranks
Trending News
More News >
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market
Advertisement

Aardvark Therapeutics, Inc. (AARD) Stock News & Sentiment

Compare
18 Followers
Buy Rating for Aardvark Therapeutics, Inc. Driven by Promising ARD-201 Obesity Treatment Potential
Premium
Ratings
Buy Rating for Aardvark Therapeutics, Inc. Driven by Promising ARD-201 Obesity Treatment Potential
4d ago
Aardvark Therapeutics Reveals Promising Preclinical Data for ARD-201
Premium
Company Announcements
Aardvark Therapeutics Reveals Promising Preclinical Data for ARD-201
4d ago
Promising Future for Aardvark Therapeutics: Buy Rating Backed by Strong Pipeline and Financial Health
Premium
Ratings
Promising Future for Aardvark Therapeutics: Buy Rating Backed by Strong Pipeline and Financial Health
5M ago

News Score - Last 7 Days

Neutral
AARD
Sector Average
Media Buzz
This Week4 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AARD’s Media Buzz Sentiment?
4 articles about AARD were published this week. In an average week, 2.25 articles are published.
    What is AARD’s weekly average amount of articles?
    In an average week, 2.25 articles about AARD are published.
      What is AARD’s News Sentiment?
      50% of articles about AARD were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        IXIIXICO plc
        KMDAKamada
        OXBDFOxford BioMedica
        VREXVarex Imaging
        BLFSBioLife Solutions
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis